FOLFIRINOX Improves PFS Compared with Gemcitabine in Patients with Locally Advanced Pancreatic Carcinoma By Ogkologos - May 26, 2025 539 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the PRODIGE 29-UCGI 26 (NEOPAN) study Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Granting a Marketing Authorisation for Generic Palbociclib Metastasis-Directed Therapy for Oligometastatic Solid Tumours in Histology-Specific Context ctDNA Testing After Neoadjuvant Chemotherapy and Radical Cystectomy Predicts Recurrence Risk in Patients with MIBC MOST POPULAR Multiple mRNA Vaccines Show Promise for Treating HPV-Related Cancers April 26, 2023 Trastuzumab Deruxtecan in Second-Line Treatment for Patients with HER2-positive Advanced Gastric... July 5, 2023 Efficacy of Rituximab Maintenance in Patients with Mantle Cell Lymphoma Who... November 28, 2023 High Sensitivity of Mismatch Repair–Deficient Locally Advanced Rectal Cancer to Single-Agent... June 8, 2022 Load more HOT NEWS Specific Lung Cancer Screening and Treatment Policies Urgently Needed to Address... “Hero” Nurses Plan Wedding In 24 Hours So Dying Patient Can... Researchers Find New, Effective Tools to Determine Breast Cancer Risk Using... Hospice Nurse Fired from Job After Being Diagnosed with Breast Cancer
